Free Trial

Cyclerion Therapeutics (KRSA) News Today

Cyclerion Therapeutics logo
$33.92 0.00 (0.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$33.87 -0.05 (-0.15%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cyclerion Therapeutics Latest News

Wedbush Begins Coverage on Cyclerion Therapeutics (NASDAQ:KRSA)
Cyclerion Therapeutics (NASDAQ:KRSA) Upgraded at Wall Street Zen
Cyclerion Therapeutics Inc.
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call
Cyclerion Therapeutics files $25M mixed securities shelf
3 US Penny Stocks With Market Caps Over $10M To Consider
Cyclerion Therapeutics announces update on next stage of growth
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Cyclerion Therapeutics Inc Ordinary Shares CYCN
Cyclerion Therapeutics (NASDAQ:KRSA) Headline
Trading was temporarily halted for "CYCN" at 09:12 AM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (NASDAQ:KRSA) Headline
Trading was temporarily halted for "CYCN" at 10:12 AM with a stated reason of "LULD pause."...

Cyclerion Therapeutics Media Mentions By Week

Cyclerion Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRSA
News Sentiment
▼
0.30

0.63
▲
Average

News Sentiment

Cyclerion Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRSA Articles
This Week
▼
6

2
▲
KRSA Articles
Average Week

Cyclerion Therapeutics Trends on MarketBeat

This week vs. last week
Searches
3
-63%
Page Views
948
-26%
Get Cyclerion Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRSA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Cyclerion Therapeutics dated 9/8/2026.
From Our Partners